Patent · US Active

Monoclonal antibodies directed to CD52

US8652470B2 · kind B2 · utility

12Cited by
7References
19Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 3, 2011
Grant dateFeb 18, 2014
Priority date—
Expiry dateOct 11, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides antibody to canine or feline or equine antigens, e.g., canine CDS2, and methods of making and using antibodies as described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.